Achillion Pharmaceuticals CEO Joseph Truitt's 2018 pay jumps 209% to $3.3M
Achillion Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 15, 2019
Achillion Pharmaceuticals reported fiscal year 2018 executive compensation information on April 15, 2019.
In 2018, six executives at Achillion Pharmaceuticals received on average a compensation package of $1.6M, a 15% increase compared to previous year.
Average pay of disclosed executives at Achillion Pharmaceuticals
Joseph Truitt, Chief Executive Officer, received $3.3M in total, which increased by 209% compared to 2017. 76% of Truitt's compensation, or $2.5M, was in option awards. Truitt also received $256K in non-equity incentive plan, $509K in salary, as well as $8.7K in other compensation.
Milind Deshpande, Chief Executive Officer, received a compensation package of $2.1M, which decreased by 6% compared to previous year. 63% of the compensation package, or $1.3M, was in option awards.
Steven Zelenkofske, Chief Medical Officer, earned $1.2M in 2018.
Paul Firuta, Chief Operating Officer, received $1.1M in 2018.
Mary Kay Fenton, Chief Financial Officer, earned $1.1M in 2018, a 9% increase compared to previous year.
Anthony Gibney, Executive Vice President and Chief Business Officer, received $1.1M in 2018.
Related executives
Joseph Truitt
Achillion Pharmaceuticals
Chief Executive Officer
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
Paul Firuta
Achillion Pharmaceuticals
Chief Operating Officer
Anthony Gibney
Achillion Pharmaceuticals
Executive Vice President and Chief Business Officer
Steven Zelenkofske
Achillion Pharmaceuticals
Chief Medical Officer
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
You may also like
Source: SEC filing on April 15, 2019.